
The Drug Controller General of India (DCGI) has approved the marketing application for Zydus Cadila’s saroglitazar to treat patients with …

The FDA announced yesterday its first successful bilateral enforcement operation with the Government of India, where they stopped 500 shipments …

The Indian government is considering an export ban on antibiotics, vitamins and hormones due to the lockdown of Hubei province, …

Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019 compared …

A recent report by the Support for Advocacy and Training to Health Initiatives (Sathi) revealed the widespread use of bribes …